C. Michael Stein
Dec. 17, 2018—Read about Vanderbilt faculty, staff, student and alumni awards, appointments and achievements.
Dec. 7, 2017—Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
Feb. 25, 2016—C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment.
Jan. 9, 2015—Growing evidence suggests that fish oil, thought to directly prevent inflammation, oxidative stress and heart disease, may have limited clinical utility.
Dec. 23, 2014—High-density lipoprotein (HDL) is known as “good cholesterol” because elevated levels protect against heart attacks and plaque buildup. However, in some cases HDL may not function properly and may actually accelerate the disease.
Aug. 21, 2014—In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.
Jul. 10, 2014—Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
May. 21, 2012—Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a “Z-pack.” The study found a 2.5-fold higher risk of death from cardiac arrhythmia in the first five days of taking azithromycin when compared with another common antibiotic or no antibiotics at all.